This site is intended only for healthcare professionals resident in the Republic of Ireland
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
VELSIPITY® helped quickly calm the chaos of UC symptoms
Symptomatic response vs placebo as early as day 21
VELSIPITY® helped calm bowel urgency vs placebo
A greater proportion of patients experienced clinically meaningful improvements in bowel urgency with VELSIPITY® vs placebo in ELEVATE UC 522
See how patients achieved endoscopic improvement with VELSIPITY®.
Adverse events should be reported.
If you wish to make a medical information inquiry or report an adverse event please contact Pfizer on 1800 633 363
or email Pfizer at [email protected] or visit www.PfizerMedicalInformation.ie
Report an adverse event to your national reporting system (HPRA Pharmacovigilance)
Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.
This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit https://www.medicines.ie
This website is brought to you by Pfizer Healthcare Ireland Unlimited Company, The Watermarque Building, Ringsend Road, Dublin 4, Dublin, Ireland, D04 K7N3.Registered in the Republic of Ireland No. 127002. Directors: M. Adamson (Managing), O. Gavan, D. Kennedy. Company Secretary: M.Byrne.
Copyright © 2025 Pfizer Limited. All rights reserved.
The information on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland and contains promotional content.
I confirm that I am a healthcare professional* resident in the Republic of Ireland.
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland Unlimited Company.
*The IPHA Code definition of a healthcare professional is a person of any of the following classes: (i) Registered medical practitioners (ii) Registered dentists (iii) Registered pharmacists (iv) Registered nurses
Terms of use
PP-UNP-IRL-0901. July 2025